vimarsana.com
Home
Live Updates
Adding Sugemalimab to CAPOX Improves Outcomes in Gastric/GEJ Adenocarcinoma : vimarsana.com
Adding Sugemalimab to CAPOX Improves Outcomes in Gastric/GEJ Adenocarcinoma
Adding sugemalimab to CAPOX improved outcomes in patients with previously untreated, advanced gastric/GEJ adenocarcinoma in a phase 3 trial.
Related Keywords
China
,
Beijing
,
Xiaotian Zhang
,
Cstone Pharmaceuticals
,
Beijing Cancer Hospital
,
vimarsana.com © 2020. All Rights Reserved.